Clinical Trial Update: An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia [Phase 2]

View source ↗

Summary

This Phase 2 exploratory trial evaluated the effects of taking GW679769 once daily for 4 days in patients with functional dyspepsia (nonulcer dyspepsia); the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• GW679769

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nonulcer Dyspepsia | Phase 2 | Status: COMPLETED